Pharma Reviews: BRIEF-Sun Pharma Gets Indian Regulatory Nod For Nafamostat Study In COVID-19 Patients

May 29 (Reuters) - Sun Pharmaceutical Industries Ltd : * RECEIVES APPROVAL FROM DCGI TO INITIATE CLINICAL TRIAL WITH NAFAMOSTAT IN ...
Read more: BRIEF-Sun Pharma Gets Indian Regulatory Nod For Nafamostat Study In COVID-19 Patients